Open AccessHigh Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers
Author(s) -
Scooter Willis,
Yuliang Sun,
Mark Abramovitz,
Fei Teng,
Brandon Young,
Xiaoqian Lin,
Min Ni,
Justin K. Achua,
Meredith M. Regan,
Kathryn P. Gray,
Robert J. Gray,
Victoria Wang,
Bradley Long,
Roswitha Kammler,
Joseph A. Sparano,
Casey Williams,
Lori J. Goldstein,
Roberto Salgado,
Sherene Loi,
Giancarlo Pruneri,
Giuseppe Viale,
Myles Brown,
Brian LeylandJones
Publication year - 2017
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.17.00009
Subject(s) - breast cancer , oncology , medicine , tamoxifen , estrogen receptor , hazard ratio , letrozole , cancer , cohort , lapatinib , proportional hazards model , trastuzumab , confidence interval
Identification of single-gene biomarkers that are prognostic of outcome can shed new insights on the molecular mechanisms that drive breast cancer and other cancers.